Free Cash Flow Chart

View Free Cash Flow for GDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 131.70M
March 31, 2026 96.54M
December 31, 2025 93.88M
September 30, 2025 104.92M
June 30, 2025 117.90M
March 31, 2025 79.11M
December 31, 2024 113.54M
September 30, 2024 88.44M
June 30, 2024 64.06M
March 31, 2024 86.50M
December 31, 2023 82.53M
Date Value
September 30, 2023 96.12M
June 30, 2023 69.45M
March 31, 2023 91.86M
December 31, 2022 91.57M
September 30, 2022 115.53M
June 30, 2022 135.62M
March 31, 2022 126.23M
December 31, 2021 144.32M
September 30, 2021 108.81M
June 30, 2021 83.73M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
LataMed AI Corp. -0.2553M
SCWorx Corp. -0.9143M
Health Catalyst, Inc. 6.551M
Claritev Corp. -17.92M
iSpecimen, Inc. -8.704M